Evaluation of Target Organs Damage in Hypertensive Patients
NCT01055353 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1857
Last updated 2011-05-12
Summary
Evaluation of target organs damage in hypertensive patients with no known cardiovascular (CV) or renal disease, stratified according to level of blood pressure control
Conditions
- Target Organs Damage
- Hypertensive
- no Known Cardiovascular
- no Known Renal Disease
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pascal Piedbois · AstraZeneca
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- France
Study Locations
More Related Trials
-
Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population
NCT00901355 ·Status: COMPLETED
-
Analysis of Antihypertensive Treatment Efficacy
NCT00767247 ·Status: TERMINATED
-
Precision Treatment With Angiotensin Converting Enzyme Inhibitor
NCT05535595 ·Status: COMPLETED ·Phase: PHASE4
-
National Survey on Hypertension in General Practitioner (GP) Consultation
NCT00695656 ·Status: COMPLETED
-
Hypertensive Treatment and Epidemiological Analyses
NCT00005501 ·Status: COMPLETED
-
National Survey on Hypertension in Cardiologic Private Practice
NCT00695175 ·Status: COMPLETED
-
Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension
NCT05638503 ·Status: RECRUITING
-
Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin
NCT03553303 ·Status: UNKNOWN ·Phase: PHASE4
-
Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives
NCT04531124 ·Status: NOT_YET_RECRUITING
-
The TARGET BP OFF-MED Trial
NCT03503773 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs
NCT03560804 ·Status: COMPLETED ·Phase: NA
-
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
NCT05732727 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy
NCT06858345 ·Status: RECRUITING
-
White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in Hypertension
NCT00005316 ·Status: COMPLETED
-
Resistant Arterial Hypertension Cohort Study
NCT01083017 ·Status: COMPLETED
-
Monitoring of the Influence of Approved PH-therapies RV-PA Coupling
NCT05935865 ·Status: RECRUITING
-
Registry of Arterial Hypertension
NCT04160533 ·Status: RECRUITING
-
Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control
NCT01932450 ·Status: UNKNOWN ·Phase: PHASE2
-
Renal Denervation for Management of Drug-Resistant Hypertension
NCT01505010 ·Status: COMPLETED ·Phase: NA
-
Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension
NCT00971165 ·Status: COMPLETED ·Phase: PHASE3
-
Changes in Renal Function and Body Composition in Pulmonary Hypertension
NCT03039972 ·Status: COMPLETED
-
Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection
NCT04354610 ·Status: COMPLETED ·Phase: NA
-
Ambulatory Blood Pressure and Prognosis
NCT00005363 ·Status: COMPLETED
-
The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.
NCT01295021 ·Status: COMPLETED
-
Angiotensin-(1-7) Cardiovascular Effects in Aging
NCT05301192 ·Status: RECRUITING ·Phase: EARLY_PHASE1